Home
Asston Pharmaceuticals Ltd Share Price History
BSE : 17 Jul, 2025
123.5-1.5 (-1.2%)
Prev Close
124.9
Open Price
124.0
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
149000
Today's High / Low
125.0 / 120.0
52 WK High / Low
125.0 / 113.1
Market Price of Asston Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Monitoring Asston Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2022 |
|---|---|
| Sales (Cr.) | 10 |
| Sales YoY Gr. | - |
| Adj EPS | 1.58 |
| YoY Gr. | - |
| Net Profit (Cr.) | 0 |
| BVPS | 13.28 |
Key Financial Parameters
| Parameter | 2022 |
|---|---|
| Return on Capital Emp. % | 13.75 |
| Op. Profit Mgn % | 6.25 |
| Net Profit Mgn % | 1.15 |
| Debt to Equity % | 3.56 |
Latest Shareholding
Promoters Holdings Over Time
About Asston Pharmaceuticals Ltd
- Asston Pharmaceuticals Limited was incorporated on 16th April 2019 as 'Asston Pharmaceutical Pvt.
- Limited' to contract produce pharmaceutical products for export market.
- Later on 1st April 2024, Company acquired Ferron Lifecare Private Limited, specializing into nutraceuticals business and produced nutraceutical products at their Ambarnath facility.
- Ferron Lifecare Private Limited, incorporated on 30th January 2020 was promoted by Dr. Ashish Sakalkar and Mr. Sachin Badakh.
- Finally, 'Asston Pharmaceuticals Private Limited' was converted from a Private Limited into a Public Limited Company in the name of 'Asston Pharmaceuticals Limited' on 29th August 2024 and received FDA approval for its Ambarnath facility on 2nd December 2024 to produce pharmaceutical products. Company is engaged in the manufacturing and export of both pharmaceutical formulations and nutraceutical products in domestic and various African markets.
Popular Search
FAQs for null Share Price History
What are the key events that typically impact Asston Pharmaceuticals Ltd's share price history?
Key events that impact Asston Pharmaceuticals Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Asston Pharmaceuticals Ltd's share price history?
Stock splits reduce the nominal price of Asston Pharmaceuticals Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Asston Pharmaceuticals Ltd?
Dividends can influence Asston Pharmaceuticals Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Asston Pharmaceuticals Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Asston Pharmaceuticals Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Asston Pharmaceuticals Ltd’s share price history?
To understand Asston Pharmaceuticals Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
